nach oben

Erschienen in:

10.06.2024 | Review

Clinical characteristics and outcomes in pseudomonas endocarditis: a systematic review of individual cases

Systematic review of pseudomonas endocarditis

verfasst von: Durga Shankar Meena, Deepak Kumar, Bhuvanesh Kumar, Gopal Krishana Bohra, Naresh Midha, Mahendra Kumar Garg

Erschienen in: Infection | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

The landscape of Pseudomonas infective endocarditis (IE) is evolving with the widespread use of cardiac implantable devices and hospital-acquired infections. This systematic review aimed to evaluate the emerging risk factors and outcomes in Pseudomonas IE.

Methods

A literature search was performed in major electronic databases (PubMed, Scopus, and Google Scholar) with appropriate keywords and combinations till November 2023. We recorded data for risk factors, diagnostic and treatment modalities. This study is registered with PROSPERO, CRD42023442807.

Results

A total of 218 cases (131 articles) were included. Intravenous drug use (IDUs) and prosthetic valve endocarditis (PVE) were major risk factors for IE (37.6% and 22%). However, the prosthetic valve was the predominant risk factor in the last two decades (23.5%). Paravalvular complications (paravalvular leak, abscess, or pseudoaneurysm) were described in 40 cases (18%), and the vast majority belonged to the aortic valve (70%). The mean time from symptom onset to presentation was 14 days. The incidence of difficult-to-treat resistant (DTR) pseudomonas was 7.4%. Valve replacement was performed in 57.3% of cases. Combination antibiotics were used in most cases (77%), with the aminoglycosides-based combination being the most frequently used (66%). The overall mortality rate was 26.1%. The recurrence rate was 11.2%. Almost half of these patients were IDUs (47%), and most had aortic valve endocarditis (76%).

Conclusions

This review highlights the changing epidemiology of Pseudomonas endocarditis with the emergence of prosthetic valve infections. Acute presentation and associated high mortality are characteristic of Pseudomonas IE and require aggressive diagnostic and therapeutic approach.

Nur mit Berechtigung zugänglich

Shah ASV, McAllister DA, Gallacher P, et al. Incidence, Microbiology, and outcomes in patients hospitalized with infective endocarditis. Circulation. 2020;141:2067–77. https://doi.org/10.1161/circulationaha.119.044913.CrossRefPubMedPubMedCentral

Slipczuk L, Codolosa JN, Davila CD, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS ONE. 2013;8:e82665. https://doi.org/10.1371/journal.pone.0082665.CrossRefPubMedPubMedCentral

Calderón Parra J, De Castro-Campos D, Muñoz García P, et al. Spanish collaboration on infectious endocarditis Group (GAMES) investigators. Non-HACEK gram negative bacilli endocarditis: analysis of a national prospective cohort. Eur J Intern Med. 2021;92:71–8. https://doi.org/10.1016/j.ejim.2021.04.021.CrossRefPubMed

Noubiap JJ, Nkeck JR, Kwondom BS, et al. Epidemiology of infective endocarditis in Africa: a systematic review and meta-analysis. Lancet Glob Health. 2022;10:e77–86. https://doi.org/10.1016/s2214-109x(21)00400-9.CrossRefPubMed

Hernández-Meneses M, Llopis J, Sandoval E, Hospital Clinic Infective Endocarditis Team Investigators, et al. Forty-year trends in Cardiac Implantable Electronic device infective endocarditis. Open Forum Infect Dis. 2022;9:ofac547. https://doi.org/10.1093%2Fofid%2Fofac547.CrossRefPubMedPubMedCentral

Schechner V, Nobre V, Kaye KS, et al. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis. 2009;48:580–6. https://doi.org/10.1086/596709.CrossRefPubMed

Falcone M, Tiseo G, Durante-Mangoni E, et al. Risk factors and outcomes of Endocarditis due to Non-HACEK gram-negative Bacilli: data from the prospective Multicenter Italian Endocarditis Study Cohort. Antimicrob Agents Chemother. 2018;62:e02208–17. https://doi.org/10.1128%2FAAC.02208-17.CrossRefPubMedPubMedCentral

Morpeth S, Murdoch D, Cabell CH, et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829–35. https://doi.org/10.7326/0003-4819-147-12-200712180-00002.CrossRefPubMed

Habib G, Lancellotti P, Antunes MJ, ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–3128. https://doi.org/10.1093/eurheartj/ehv319.

10.

Ortega-Loubon C, Muñoz-Moreno MF, Andrés-García I, et al. Nosocomial Vs. Community-Acquired Infective endocarditis in Spain: location, trends, clinical presentation, etiology, and Survival in the 21st Century. J Clin Med. 2019;8:1755. https://doi.org/10.3390/jcm8101755.CrossRefPubMedPubMedCentral

11.

Moher D, Liberati A, Tetzlaff J, PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. https://doi.org/10.1371/journal.pmed.1000097.CrossRefPubMedPubMedCentral

12.

Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8. https://doi.org/10.1086/313753.CrossRefPubMed

13.

Fowler VG, Durack DT, Selton-Suty C, et al. The 2023 Duke-International Society for Cardiovascular Infectious diseases Criteria for Infective endocarditis: updating the modified Duke Criteria. Clin Infect Dis. 2023;77:518–26. https://doi.org/10.1093/cid/ciad271.CrossRefPubMedPubMedCentral

14.

Kadri SS, Adjemian J, Lai YL, National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI), et al. Difficult-to-treat resistance in Gram-negative bacteremia at 173 US hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and outcome of resistance to all first-line agents. Clin Infect Dis. 2018;67:1803–14. https://doi.org/10.1093/cid/ciy378.CrossRefPubMedPubMedCentral

15.

Moola S, Munn Z, Tufanaru C, et al. Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. Editors). JBI Manual for evidence synthesis. JBI; 2020. http://synthesismanual.jbi.global. https://doi.org/10.46658/JBIMES-20-08.

16.

Aubron C, Charpentier J, Trouillet JL, et al. Native-valve infective endocarditis caused by Enterobacteriaceae: report on 9 cases and literature review. Scand J Infect Dis. 2006;38:873–81. https://doi.org/10.1080/00365540600740488.CrossRefPubMed

17.

Tuon FF, Dantas LR, Suss PH, et al. Pathogenesis of the Pseudomonas aeruginosa Biofilm: a review. Pathogens. 2022;11:300. https://doi.org/10.3390%2Fpathogens11030300.CrossRefPubMedPubMedCentral

18.

Lin TI, Huang YF, Liu PY, et al. Pseudomonas aeruginosa infective endocarditis in patients who do not use intravenous drugs: analysis of risk factors and treatment outcomes. J Microbiol Immunol Infect. 2016;49:516–22. https://doi.org/10.1016/j.jmii.2014.08.019.CrossRefPubMed

19.

Raza SS, Sultan OW, Sohail MR. Gram-negative bacterial endocarditis in adults: state-of-the-heart. Expert Rev Anti Infect Ther. 2010;8:879–85. https://doi.org/10.1586/eri.10.76.CrossRefPubMed

20.

Rosenberg I, Leibovici L, Mor F, et al. Pseudomonas stutzeri causing late prosthetic valve endocarditis. J R Soc Med. 1987;80:457–9. https://doi.org/10.1177/014107688708000719.CrossRefPubMedPubMedCentral

21.

Aragone MR, Maurizi DM, Clara LO, et al. Pseudomonas mendocina, an environmental bacterium isolated from a patient with human infective endocarditis. J Clin Microbiol. 1992;30:1583–4. https://doi.org/10.1128/jcm.30.6.1583-1584.1992.CrossRefPubMedPubMedCentral

22.

Baddour LM, Wilson WR, Bayer AS, American Heart Association Committee on Rheumatic Fever, et al. Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular surgery and anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: A Scientific Statement for Healthcare professionals from the American Heart Association. Circulation. 2015;132:1435–86. https://doi.org/10.1161/circulationaha.105.165564.CrossRefPubMed

23.

van der Vaart TW, Prins JM, Soetekouw R, et al. Prediction rules for ruling out endocarditis in patients with Staphylococcus aureus Bacteremia. Clin Infect Dis. 2022;74:1442–49. https://doi.org/10.1093/cid/ciab632.CrossRefPubMed

24.

Berge A, Krantz A, Östlund H, et al. The DENOVA score efficiently identifies patients with monomicrobial Enterococcus faecalis bacteremia where echocardiography is not necessary. Infection. 2019;47:45–50. https://doi.org/10.1007/s15010-018-1208-3.CrossRefPubMed

25.

Covino M, De Vita A, d’Aiello A, et al. A New Clinical Prediction Rule for Infective endocarditis in Emergency Department patients with fever: definition and first validation of the CREED score. J Am Heart Assoc. 2023;12:e027650. https://doi.org/10.1161/jaha.122.027650.CrossRefPubMedPubMedCentral

26.

Thornhill MH, Jones S, Prendergast B, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J. 2018;39:586–95. https://doi.org/10.1093/eurheartj/ehx655.CrossRefPubMed

27.

de Sousa LP, Fortes CQ, Damasco PV, et al. Infective endocarditis due to Non-HACEK gram-negative Bacilli: clinical characteristics and risk factors from a prospective Multicenter Brazilian cohort. Trop Med Infect Dis. 2023;8:283. https://doi.org/10.3390/tropicalmed8050283.CrossRefPubMedPubMedCentral

28.

Salem M, Friedrich C, Saad M, et al. Active infective native and prosthetic valve endocarditis: short- and long-term outcomes of patients after Surgical Treatment. J Clin Med. 2021;10:1868. https://doi.org/10.3390/jcm10091868.CrossRefPubMedPubMedCentral

29.

Mahmoud K, Hammouda T, Kandil H, et al. Prevalence and predictors of aortic root abscess among patients with left-sided infective endocarditis: a cross-sectional comparative study. Egypt Heart J. 2020;72:62. https://doi.org/10.1186/s43044-020-00098-6.CrossRefPubMedPubMedCentral

30.

Gürtler N, Osthoff M, Rueter F, et al. Prosthetic valve endocarditis caused by Pseudomonas aeruginosa with variable antibacterial resistance profiles: a diagnostic challenge. BMC Infect Dis. 2019;19:530. https://doi.org/10.1186%2Fs12879-019-4164-3.CrossRefPubMedPubMedCentral

31.

Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group, et al. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis. Lancet Reg Health Eur. 2023;34:100736. https://doi.org/10.1016/j.lanepe.2023.100736.CrossRefPubMedPubMedCentral

32.

Giannella M, Bussini L, Pascale R, et al. Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections. Open Forum Infect Dis. 2019;6:ofz505. https://doi.org/10.1093%2Fofid%2Fofz505.CrossRefPubMedPubMedCentral

33.

Walczak A, McCarthy K, Paterson DL. A contemporary case series of Pseudomonas aeruginosa infective endocarditis. Med (Baltim). 2023;102:e32662. https://doi.org/10.1097/MD.0000000000032662.CrossRef

34.

Paul M, Leibovici L. Editorial commentary: combination therapy for Pseudomonas aeruginosa bacteremia: where do we stand? Clin Infect Dis. 2013;57:217–20. https://doi.org/10.1093/cid/cit220.CrossRefPubMed

35.

Shah S, Clarke LG, Shields RK. Epidemiology and clinical outcomes of Non-HACEK gram-negative infective endocarditis. Open Forum Infect Dis. 2023;10:ofad052. https://doi.org/10.1093/ofid/ofad052.CrossRefPubMedPubMedCentral

36.

Lorenz A, Sobhanie MME, Orzel L, et al. Clinical outcomes of combination versus monotherapy for gram negative non-HACEK infective endocarditis. Diagn Microbiol Infect Dis. 2021;101:115504. https://doi.org/10.1016/j.diagmicrobio.2021.115504.CrossRefPubMedPubMedCentral

37.

Babich T, Naucler P, Valik JK, et al. Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study. J Antimicrob Chemother. 2021;76:2172–81. https://doi.org/10.1093/jac/dkab134.CrossRefPubMed

38.

Edgeworth JD, Merante D, Patel S, et al. Compassionate use of Cefiderocol as Adjunctive Treatment of native aortic valve endocarditis due to extremely drug-resistant Pseudomonas aeruginosa. Clin Infect Dis. 2019;68:1932–34. https://doi.org/10.1093/cid/ciy963.CrossRefPubMed

39.

Tascini C, Antonelli A, Pini M, et al. Infective Endocarditis Associated with Implantable Cardiac device by Metallo-β-Lactamase-Producing Pseudomonas aeruginosa, successfully treated with Source Control and Cefiderocol Plus Imipenem. Antimicrob Agents Chemother. 2023;67:e0131322. https://doi.org/10.1128/aac.01313-22.CrossRefPubMed

Titel: Clinical characteristics and outcomes in pseudomonas endocarditis: a systematic review of individual cases
Systematic review of pseudomonas endocarditis
verfasst von: Durga Shankar Meena
Deepak Kumar
Bhuvanesh Kumar
Gopal Krishana Bohra
Naresh Midha
Mahendra Kumar Garg
Publikationsdatum: 10.06.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Infection / Ausgabe 5/2024
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-024-02311-z

Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)

Open Access
Research

Epidemiological trends and susceptibility patterns of bloodstream infections caused by Enterococcus spp. in six German university hospitals: a prospectively evaluated multicentre cohort study from 2016 to 2020 of the R-Net study group

Open Access
Research

Malaria vaccine efficacy, safety, and community perception in Africa: a scoping review of recent empirical studies

Open Access
Review

Correspondence: serum neutralization of SARS-CoV-2 Omicron sublineages BA.1, BA.2 and BA.5 in lung transplant recipients receiving prophylactic tixagevimab/cilgavimab

Correspondence

Sapovirus: an emerging pathogen in kidney transplant recipients?

Open Access
Research

High cure rates of Mycoplasma genitalium following empiric treatment with azithromycin alongside frequent detection of macrolide resistance in Austria

Open Access
Research

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

17.01.2025
Dekubitus
Nachrichten

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Schützt das tägliche Glas Milch vor Darmkrebs?

17.01.2025
Kolorektales Karzinom
Nachrichten

Die Milch machts – sie bietet Frauen nach Daten einer großen Ernährungsanalyse den besten Darmkrebsschutz aller Lebensmittel, was am hohen Kalziumgehalt liegen dürfte. Am anderen Ende des Spektrums steht der Alkoholkonsum: Das Glas Wein am Abend ist eher ungünstig.

Vorsicht mit Glukokortikoiden bei Glomerulopathie

16.01.2025
Primäre Glomerulonephritiden
Nachrichten

Auch niedrig dosierte Glukokortikoide zur Behandlung einer primären Glomerulopathie lassen offenbar die Infektionsgefahr steigen. In einer US-Studie hing das Risiko vor allem mit der kombinierten Anwendung von Immunsuppressiva zusammen.

KI-gestütztes Mammografiescreening überzeugt im Praxistest

16.01.2025
Künstliche Intelligenz im Gesundheitswesen
Nachrichten

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Clinical characteristics and outcomes in pseudomonas endocarditis: a systematic review of individual cases

Systematic review of pseudomonas endocarditis